About Orakl Oncology
Orakl Oncology is a company based in Villejuif (France) founded in 2023 by Diane-Laure Pages, Gustave Ronteix, and Fanny Jaulin.. Orakl Oncology has raised $14.7 million across 2 funding rounds from investors including Speedinvest, Bpifrance and HCVC. Orakl Oncology offers products and services including Precision Medicine Services. Orakl Oncology operates in a competitive market with competitors including Oncodesign, LumaBridge, Lytica Therapeutics, Orange Grove Bio LLC and Axios Biosciences, among others.
- Headquarter Villejuif, France
- Founders Diane-Laure Pages, Gustave Ronteix, Fanny Jaulin
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Orakl Oncology Sas
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.7 M (USD)
in 2 rounds
-
Latest Funding Round
$11.56 M (USD), Seed
Dec 03, 2024
-
Investors
Speedinvest
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orakl Oncology
Orakl Oncology offers a comprehensive portfolio of products and services, including Precision Medicine Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Services to accelerate oncology drug development through partnerships
Funding Insights of Orakl Oncology
Orakl Oncology has successfully raised a total of $14.7M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $11.56 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $11.6M
-
First Round
First Round
(04 Oct 2023)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Seed - Orakl Oncology | Valuation | Singular | |
| Oct, 2023 | Amount | Seed - Orakl Oncology | Valuation | Speedinvest |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orakl Oncology
Orakl Oncology has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Speedinvest, Bpifrance and HCVC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are made in European startups.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital and startup acceleration are provided.
|
Founded Year | Domain | Location | |
|
Investments are directed toward hard-tech and full-stack companies by HCVC.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orakl Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orakl Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orakl Oncology Comparisons
Competitors of Orakl Oncology
Orakl Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oncodesign, LumaBridge, Lytica Therapeutics, Orange Grove Bio LLC and Axios Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Preclinical assessment services for anti-cancer therapies are provided.
|
|
| domain | founded_year | HQ Location |
Provider of oncology clinical research, regulatory affairs, and data management services
|
|
| domain | founded_year | HQ Location |
Therapeutic drugs are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Provider of preclinical development services
|
|
| domain | founded_year | HQ Location |
Creates innovative platforms for anti-cancer drug development.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orakl Oncology
Frequently Asked Questions about Orakl Oncology
When was Orakl Oncology founded?
Orakl Oncology was founded in 2023.
Where is Orakl Oncology located?
Orakl Oncology is headquartered in Villejuif, France.
Who is the current CEO of Orakl Oncology?
Fanny Jaulin is the current CEO of Orakl Oncology. They have also founded this company.
Is Orakl Oncology a funded company?
Orakl Oncology is a funded company, having raised a total of $14.7M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3.14M, raised on Oct 04, 2023.
What does Orakl Oncology do?
Orakl Oncology is a precision oncology start-up that partners with Gustave Roussy, one of the worlds top cancer centers, to connect patient tumors and enable the emergence of rare oncology. They have recently raised 3 million to develop their techbio platform for precision oncology.
Who are the top competitors of Orakl Oncology?
Orakl Oncology's top competitors include Oncodesign, Lytica Therapeutics and Orange Grove Bio LLC.
What products or services does Orakl Oncology offer?
Orakl Oncology offers Precision Medicine Services.
Who are Orakl Oncology's investors?
Orakl Oncology has 5 investors. Key investors include Speedinvest, Bpifrance, HCVC, Singular, and Verve Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.